X - hyaluronic acid sodium powder

País: Estados Unidos

Idioma: inglés

Fuente: NLM (National Library of Medicine)

Ingredientes activos:

HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONATE SODIUM - UNII:YSE9PPT4TH)

Disponible desde:

AX Pharmaceutical Corp

Designación común internacional (DCI):

HYALURONATE SODIUM

Composición:

HYALURONATE SODIUM 99 g in 100 g

Vía de administración:

NOT APPLICABLE

Estado de Autorización:

Bulk Ingredient For Animal Drug Compounding

Ficha técnica

X - HYALURONIC ACID SODIUM POWDER
AX PHARMACEUTICAL CORP
----------
X
AX Pharmaceutical Corp
hyaluronic acid sodium powder
PRODUCT INFORMATION
PRODUCT T YPE
BULK INGREDIENT
ITE M CODE (SOURCE )
NDC:6 2157-0 73
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
HYALURO NATE SO DIUM (UNII: YSE9 PPT4TH) (HYALURONATE SODIUM -
UNII:YSE9 PPT4TH)
HYALURONATE
SODIUM
9 9 g
in 10 0 g
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
WATER (UNII: 0 59 QF0 KO0 R)
PRODUCT CHARACTERISTICS
COLOR
white (white)
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:6 2157-0 73-0 1
10 0 g in 1 BOTTLE
0 5/22/20 15
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH
CITA TIO N
MARKE TING START
DATE
MARKE TING END
DATE
BULK INGREDIENT FOR ANIMAL DRUG
COMPOUNDING
0 5/22/20 15
LABELER -
AX Pharmaceutical Corp (202924858)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
AX Pharmaceutical Co rp
20 29 248 58
repack(6 2157-0 73) , relabel(6 2157-0 73)
Revised: 9/2016